University of Chicagochicago, IL, United States
Disclosures:
2158 - A First-in-Human Study of the Radiopharmaceutical [225Ac]-FPI-2068 in Patients (pts) with Advanced Solid Tumors
Sunday, September 29, 20242:45 PM – 4:15 PM ET